UniCredit Knock-Out AMD 13.11.202.../ DE000HD72930 /
30/10/2024 14:28:47 | Var.-0.040 | Denaro20:58:42 | Lettera30/10/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
9.860EUR | -0.40% | - Quantità in denaro: - |
- Quantità in lettera: - |
ADVANCED MIC.DEV. D... | - - | 13/11/2024 | Call |
GlobeNewswire
01/09
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
27/08
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
27/08
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
26/08
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
23/08
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...